Cigarette smoking and diabetic nephropathy

Contributions to Nephrology

Volumn 130, Issue , 2000, Pages 85-93

  Krimholtz, Mike ^a,b   Thomas, Stephen ^a   Viberti, Giancarlo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; INSULIN RESISTANCE; KIDNEY CIRCULATION; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; THROMBOCYTE; VASCULAR ENDOTHELIUM;

BLOOD PLATELETS; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; INSULIN RESISTANCE; RENAL CIRCULATION; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 0033660944     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060045     Document Type: Article

References (42)

1. Muhlhause I, Sawicki P, Berger M: Cigarette smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 1986;29:500-502.
2. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Baddock N, Henning P: Relationship of smoking and albuminuria in children with insulin-dependent diabetes: Diabet Med 1994;11:666-669.
3. Stegmayer BG: A study of patients with diabetes mellitus (type 1) and end-stage renal failure: Tobacco usage may increase risk of nephropathy and death. J Intern Med 1990;228:121-124.
4. Olivaruis N, Andreasen AH, Keiding N, Mogensen CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients.Cross-sectional data from the populationbased study 'Diabetes Care in General Practice', Denmark. Diabetologia 1993;36:1007-1016.
5. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E: Proteinuria and mortality in diabetes: The WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 1995;12:149-155.
6. Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ: Albuminuria in people at least 40 years old: Effect of alcohol consumption, regular exercise, and cigarette smoking. Clin Chem 1993;39:1793-1797.
7. Bott U, Jorgens V, Grusser M, Bender R, Muhlhauser I, Berger M: Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 1994;11:362-371.
8. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, Deambrogio P, Pagano G: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 1996;19:43-47.
9. Norden G, Nyberg G: Smoking and diabetic nephropathy. Acta Med Scand 1984;215:257-261.
10. 10a Bradford Hill A: The environment and disease: Association or causation. Proc R Soc Med 1965; 58:295-300.
11. 10b Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE: Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA 1991;265:614-617.
12. The Microalbuminuria Collaborative Study Group: Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: A seven year prospective study. Diabet Med 1999;16:918-925.
13. Forsblom CM, Groop PH, Ekstrand A, Totterman KJ, Sane T, Saloranta C, Groop L: Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 1998;21:1932-1938.
14. Mattock MB, Barnes DJ, Vibreti G, Keen H, Burt D, Hughes JM, Fitzgerald AP, Sandhu B, Jackson PG: Microalbuminuria and coronary heart disease in NIDDM: An incidence study. Diabetes 1998; 47:1786-1792.
15. Klein R, Klein BE, Moss SE: Incidence of gross proteinuria in older-onset diabetes: A populationbased perspective. Diabetes 1993;42:381-389.
16. Klein R, Klein BE, Moss SE, Cruickshanks KJ: Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 1995;44:916-923.
17. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinermann L, Berger M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994;17:126-131.
18. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 1994;9:1097-1102.
19. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
20. Moy CS, LaPorte RE, Dorman JS, Songer TJ, Orchard TJ, Kuller LH, Becker DJ, Drash AL: Insulin-dependent diabetes mellitus mortality: The risk of cigarette smoking. Circulation 1990;82:37-43.
21. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH: Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303-1309.
22. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G: Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-741.
23. Stegmayr B, Lithner F: Tobacco and end stage diabetic nephropathy. Br Med J Clin Res Ed 1987; 295:581-582.
24. Biesenbach G, Zazgornik J: Influence of smoking on the survival rate of diabetic patients requiring hemodialysis. Diabetes Care 1996;19:625-628.
25. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995;310:555-559.
26. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM: Insulin resistance and cigarette smoking. Lancet 1992;339:1128-1130.
27. Uchimoto S, Tsumura K, Hayashi T, Suematsu C, Endot G, Gujii S, Okada K: Impact of cigarette smoking on the incidence of type 2 diabetes mellitus in middle-aged Japanese men: The Osaka health survey. Diabet Med 1999;16:951-955.
28. Helve E, Yki-Jarvinen H, Koivisto VA: Smoking and insulin sensitivity in type I diabetic patients. Metabolism 1986;35:874-877.
29. Nicholson JP, Teichman SL, Alderman MH, Sos TA, Pickering TG, Laragh JH: Cigarette smoking and renovascular hypertension. Lancet 1983;ii:765-766.
30. Anderson S: Role of local and systemic angiotensin in diabetic renal disease. Kidney Int 1997; (suppl 63):S107-S110.
31. Ritz E, Benck U, Franek E, Keller C, Seyfarth M, Clorius J: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 1998;9:1798-1804.
32. Ekberg G, Grefberg N, Larsson LO, Vaara I: Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy. J Intern Med 1990;228:211-217.
33. Cryer PE, Haymond MW, Santiago JV, Shah SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
34. Baer L, Radichevich I: Cigarette smoking in hypertensive pateints. Blood pressure and endocrine responses. Am J Med 1985;78:564-568.
35. Rowe JW, Kilgore A, Robertson GL: Evidence in man that cigarette smoking induces vasopression release via an airway-specific mechanism. J Clin Endocrinol Metab 1980;51:170-172.
36. Nitenberg A, Antony I: Coronary vascular endothelium, a common target in patients with diabetes mellitus, cigarette smoking, hypercholesterolaemia, hypertension and menopausal status. Nephrol Dial Transplant 1998;13(suppl 4):16-19.
37. Nadler JL, Velasco JS, Horton R: Cigarette smoking inhibits prostacyclin formation. Lancet 1983; i:1248-1250.
38. Perry RJ, Griffiths W, Dextraze P, Solomon RJ, Trebbin WM: Elevated nicotine levels in patients undergoing hemodialysis: A role in cardiovascular mortality and morbidity. Am J Med 1984;76:241-246.
39. Bern MM: Platelet functions in diabetes mellitus. Diabetes 1978;27:342-350.
40. Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-68.
41. Davis JW, Arnold J, Wiegmann T: Cigarette smoking affects platelets and endothelium in chronic hemodialysis patients. Nephron 1993;64:359-364.
42. Noronha-Dutra AA, Epperlein MM, Woolf N: Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc Res 1993;27:774-778.